Impact of Previous Local Treatment for Brain Metastases on Response to Molecular Targeted Therapy in BRAF-Mutant Melanoma Brain Metastasis: A Systematic Review and Meta-Analysis

BACKGROUND: Melanoma brain metastases (BMs) are associated with poor prognosis and are the main cause of mortality in melanoma patients. BRAF inhibitors have shown intracranial activity in both treatment-naïve and previously treated BM patients. We aimed to investigate if there was any difference in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Guixiang, Fu, Yuxiang, Arooj, Sumbal, Khan, Muhammad, Li, Xianming, Yan, Maosheng, Li, Zihuang, Yang, Hongli, Zheng, Tao, Xu, Ruilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263360/
https://www.ncbi.nlm.nih.gov/pubmed/35814449
http://dx.doi.org/10.3389/fonc.2022.704890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263360/
https://www.ncbi.nlm.nih.gov/pubmed/35814449
http://dx.doi.org/10.3389/fonc.2022.704890

Ejemplares similares